Zevra Therapeutics, Inc. is a high-risk pharmaceutical company based in the United States that focuses on developing innovative therapies for rare diseases. The company utilizes a unique combination of science, data, and patient needs to create life-changing treatments for individuals with limited treatment options. Zevra Therapeutics is committed to bringing transformational therapies to the rare disease community by overcoming complex drug development challenges through ESG strategies.